Press Releases June 9, 2026 04:30 PM

Hooker Furnishings Declares Quarterly Dividend

Hooker Furnishings Declares Quarterly Dividend, Reflecting Solid Financial Position

By Jordan Park
Share
Twitter Reddit Facebook LinkedIn
HOFT

Hooker Furnishings Corporation announces a quarterly cash dividend of $0.115 per share, payable June 30, 2026, reinforcing its stable cash flow and commitment to shareholder returns. The company, with over a century in the furniture industry, continues to serve residential, hospitality, and contract markets with a diverse portfolio of furniture and home décor products.

Hooker Furnishings Declares Quarterly Dividend
HOFT
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Board declared a quarterly cash dividend of $0.115 per share payable to shareholders on record as of June 19, 2026.
  • Company operates a broad range of furniture divisions including residential casegoods, upholstered seating, hospitality, and outdoor furniture.
  • Hooker Furnishings has a diversified manufacturing and distribution network across the U.S. and Vietnam, highlighting its global operational footprint.

MARTINSVILLE, Va., June 09, 2026 (GLOBE NEWSWIRE) -- Hooker Furnishings Corporation (Nasdaq-GS: HOFT) announced that on June 9, 2026, its board of directors declared a quarterly cash dividend of $0.115 per share, payable on June 30, 2026, to shareholders of record on June 19, 2026.

Hooker Furnishings Corporation, in its 102nd year of business, is a designer, marketer and importer of casegoods (wooden and metal furniture), leather furniture, fabric-upholstered furniture, lighting, accessories, and home décor for the residential, hospitality and contract markets. The Company also domestically manufactures premium residential custom leather and custom fabric-upholstered furniture and outdoor furniture. Major casegoods product categories include home entertainment, home office, accent, dining, and bedroom furniture in the upper-medium price points sold under the Hooker Furniture brand. Hooker’s residential upholstered seating product lines include Bradington-Young, a specialist in upscale motion and stationary leather furniture, HF Custom (formerly Sam Moore), a specialist in fashion forward custom upholstery offering a selection of chairs, sofas, sectionals, recliners and a variety of accent upholstery pieces, Hooker Upholstery, imported upholstered furniture targeted at the upper-medium price-range and Shenandoah Furniture, an upscale upholstered furniture company specializing in private label sectionals, modulars, sofas, chairs, ottomans, benches, beds and dining chairs in the upper-medium price points for lifestyle specialty retailers. The H Contract product line supplies upholstered seating and casegoods to upscale senior living facilities. The Samuel Lawrence Hospitality is a designer and supplier of hotel furnishings. The Sunset West division is a designer and manufacturer of comfortable, stylish and high-quality outdoor furniture. Hooker Furnishings Corporation’s corporate offices and upholstery manufacturing facilities are located in Virginia, North Carolina and California, with showrooms in High Point, NC, Las Vegas, NV, Atlanta, GA and Ho Chi Minh City, Vietnam. The company operates distribution centers in Virginia and Vietnam. Please visit our websites hookerfurnishings.com, hookerfurniture.com, bradington-young.com, hfcustomfurniture.com, hcontractfurniture.com, slh-co.com, and sunsetwestusa.com.

For more information, contact:
C. Earl Armstrong, Senior Vice President-Finance and CFO
Hooker Furnishings Corporation, 276.666.3969


Risks

  • Market demand for furniture products could be impacted by economic downturns affecting consumer spending in residential and hospitality sectors.
  • Supply chain disruptions or increased costs in manufacturing and distribution could affect profitability.
  • Competition in the furniture industry may pressure margins and growth potential.

More from Press Releases

Can-Fite Reports Q2 2026 Financial Results and Ongoing Clinical Progress Highlighting Longer-Than-Anticipated Overall Survival in Ongoing Pivotal Phase III Liver Cancer Study Sep 8, 2026 Veru Advances Oral Sabizabulin Following Positive Preclinical Data Showing Potent Anticancer Activity in Human Daraxonrasib (Revolution Medicines’ RASONQUE™) Resistant Pancreatic Cancer into a Planned Phase 2 Clinical Trial Sep 8, 2026 GRI Bio Presents New Phase 2a Data at ERS 2026 Defining GRI-0621's Mechanism of Action in IPF Across Nine Mechanistic Pillars Sep 8, 2026 Worthington Enterprises Schedules Fiscal First Quarter 2027 Earnings Call for September 23 Sep 8, 2026 Phillips Edison & Company to Participate in Webcast Panel at Barclays 24th Annual Financial Services Conference Sep 8, 2026